AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

7,680.00p
   
  • Change Today:
      6.00p
  • 52 Week High: 9,320.00
  • 52 Week Low: 6,794.00
  • Currency: UK Pounds
  • Shares Issued: 1,312.75m
  • Volume: 1,479,371
  • Market Cap: £100,820m
  • RiskGrade: 123
  • Beta: 0.00

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart (06-05-2021)

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 2.6% 2.7%
Div Cover 0.9 1.9
Op Mrgn 19.4% 28.2%
ROCE 76.3%  
Latest F'cast
P/E 43.7 20.0
PEG 0.3 0.2
Pr/Revenue 5.3 4.5
Pr/Book 9.0  
Latest F'cast
Revenue 9.2% -39.4%
PBT 153.0% 16.3%
EPS 136.9% 118.0%
DPS n/a n/a

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 23,002.00 3,552.00 431.00¢ 14.3 14.3 +1% 280.00¢ 4.5%
31-Dec-17 22,465.00 2,227.00 428.00¢ 16.6 n/a -1% 280.00¢ 3.9%
31-Dec-18 22,090.00 1,993.00 170.00¢ 48.1 n/a -60% 280.00¢ 3.4%
31-Dec-19 24,384.00 1,548.00 103.00¢ 102.7 n/a -39% 280.00¢ 2.6%
31-Dec-20 26,617.00 3,916.00 244.00¢ 41.8 0.3 +137% 280.00¢ 2.7%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 22,433.07 6,333.51 384.79p 20.0 0.2 +118% 204.83p 2.7%
31-Dec-22 26,405.72 8,488.05 487.89p 15.7 0.6 +27% 211.81p 2.7%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

Holding(s) in Company 05-May-2021 18:30 RNS
Total Voting Rights 04-May-2021 15:00 RNS
Farxiga approved in the US for CKD 04-May-2021 07:00 RNS

Latest AstraZeneca Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 7,680.00p
Change Today 6.00p
% Change 0.08 %
52 Week High 9,320.00
52 Week Low 6,794.00
Volume 1,479,371
Shares Issued 1,312.75m
Market Cap £100,820m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.57% below the market average73.57% below the market average73.57% below the market average73.57% below the market average73.57% below the market average
61.54% above the sector average61.54% above the sector average61.54% above the sector average61.54% above the sector average61.54% above the sector average
Price Trend
52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average
40.35% below the sector average40.35% below the sector average40.35% below the sector average40.35% below the sector average40.35% below the sector average
Income
13.15% below the market average13.15% below the market average13.15% below the market average13.15% below the market average13.15% below the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Growth
89.37% above the market average89.37% above the market average89.37% above the market average89.37% above the market average89.37% above the market average
89.47% above the sector average89.47% above the sector average89.47% above the sector average89.47% above the sector average89.47% above the sector average

What The Brokers Say

Strong Buy 22
Buy 2
Neutral 2
Sell 0
Strong Sell 1
Total 27
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 25-Feb-21 13-Aug-20
Paid 29-Mar-21 14-Sep-20
Amount 190.00¢ 90.00¢

Trades for 06-May-2021

Time Volume / Share Price
16:45 46 @ 7,670.00p
16:45 46 @ 7,670.00p
16:35 62,370 @ 7,666.97p
16:35 1,000 @ 7,680.00p
16:35 412,787 @ 7,680.00p

Top of Page